University of Michigan Frankel Cardiovascular Center and Institute for Healthcare Policy and Innovation, 2800 Plymouth Rd, B14 G214, Ann Arbor, MI, 48109-2800, USA.
University of Michigan Center for Bioethics and Social Science in Medicine, Ann Arbor, USA.
Implement Sci. 2020 Sep 21;15(1):83. doi: 10.1186/s13012-020-01044-5.
Use of direct oral anticoagulants (DOAC) is rapidly growing for treatment of atrial fibrillation and venous thromboembolism. However, incorrect dosing of these medications is common and puts patients at risk of adverse drug events. One way to improve safe prescribing is the use of population health tools, including interactive dashboards built into the electronic health record (EHR). As such tools become more common, exploring ways to understand which aspects are effective in specific settings and how to effectively adapt and implement in existing anticoagulation clinics across different health systems is vital.
This three-phase project will evaluate a current nation-wide implementation effort of the DOAC Dashboard in the Veterans Health Administration (VHA) using both quantitative and qualitative methods. Informed by this evaluation, the DOAC Dashboard will be implemented in four new health systems using an implementation strategy derived from the VHA experience and interviews with providers in those new health systems. Quantitative evaluation of the VHA and non-VHA implementation will follow the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) framework. Qualitative interviews with stakeholders will be analyzed using the Consolidated Framework for Implementation Research and Technology Acceptance Models to identify key determinants of implementation success.
This study will (1) evaluate the implementation of an EHR-based population health tool for medication management within a large, nation-wide, highly integrated health system; (2) guide the adoption in a set of four different health systems; and (3) evaluation that multi-center implementation effort. These findings will help to inform future EHR-based implementation efforts in a wide variety of health care settings.
直接口服抗凝剂(DOAC)在治疗心房颤动和静脉血栓栓塞症方面的应用正在迅速增长。然而,这些药物的剂量不正确很常见,会使患者面临药物不良事件的风险。改善安全处方的一种方法是使用人群健康工具,包括内置在电子健康记录(EHR)中的交互式仪表板。随着这些工具变得越来越普遍,探索了解在特定环境中哪些方面有效以及如何在不同的医疗系统中的现有抗凝诊所中有效适应和实施的方法至关重要。
本三阶段项目将使用定量和定性方法评估退伍军人事务部(VHA)中 DOAC 仪表板的当前全国实施情况。根据该评估结果,将使用源自 VHA 经验和对这些新医疗系统中提供者的访谈的实施策略,在四个新的医疗系统中实施 DOAC 仪表板。将根据 Reach、Effectiveness、Adoption、Implementation、Maintenance(RE-AIM)框架对 VHA 和非 VHA 的实施进行定量评估。将使用实施研究和技术接受模型的综合框架对利益相关者的定性访谈进行分析,以确定实施成功的关键决定因素。
本研究将:(1)评估在一个大型、全国性、高度集成的医疗系统中基于 EHR 的药物管理人群健康工具的实施情况;(2)指导在四个不同医疗系统中的采用;(3)评估多中心实施工作。这些发现将有助于为各种医疗保健环境中的未来基于 EHR 的实施工作提供信息。